Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria.
about
Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Micro - Focused Phototherapy Associated To Janus Kinase Inhibitor: A Promising Valid Therapeutic Option for Patients with Localized Vitiligo.
P2860
Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Brief Report: Remission Rates ...... of Various Remission Criteria.
@en
Brief Report: Remission Rates ...... of Various Remission Criteria.
@nl
type
label
Brief Report: Remission Rates ...... of Various Remission Criteria.
@en
Brief Report: Remission Rates ...... of Various Remission Criteria.
@nl
prefLabel
Brief Report: Remission Rates ...... of Various Remission Criteria.
@en
Brief Report: Remission Rates ...... of Various Remission Criteria.
@nl
P2093
P2860
P356
P1476
Brief Report: Remission Rates ...... of Various Remission Criteria.
@en
P2093
Charles Mebus
Daniel Aletaha
David Gruben
Samuel H Zwillich
Sriram Krishnaswami
P2860
P304
P356
10.1002/ART.39996
P577
2016-12-01T00:00:00Z